FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

James Sisson

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Anatomy

Living Beings

Infants

Co-author Network

Publications

TOP 3
James C Sisson; Gregory Yanik
Theranostics: evolution of the radiopharmaceutical meta-iodobenzylguanidine in endocrine tumors.
James C Sisson; Thomas J Giordano; Anca M Avram
Three endocrine neoplasms: an unusual combination of pheochromocytoma, pituitary adenoma, and papillary thyroid carcinoma.
Ka Kit Wong; James C Sisson; Kenneth F Koral; Kirk A Frey; Anca M Avram
Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of James Sisson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: James C Sisson; Gregory Yanik
Theranostics: evolution of the radiopharmaceutical meta-iodobenzylguanidine in endocrine tumors.
Seminars in nuclear medicine 2012;42(3):171-84.
2012: James C Sisson; Thomas J Giordano; Anca M Avram
Three endocrine neoplasms: an unusual combination of pheochromocytoma, pituitary adenoma, and papillary thyroid carcinoma.
Thyroid : official journal of the American Thyroid Association 2012;22(4):430-6.
2010: Ka Kit Wong; James C Sisson; Kenneth F Koral; Kirk A Frey; Anca M Avram
Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT.
AJR. American journal of roentgenology 2010;195(3):730-6.
2009: Monica L Marvin; Carol R Bradford; James C Sisson; Stephen B Gruber
Diagnosis and management of hereditary paraganglioma syndrome due to the F933>X67 SDHD mutation.
Head & neck 2009;31(5):689-94.
2009: James C Sisson; Yuni K Dewaraja; Eric J Wizauer; Thomas J Giordano; Anca M Avram
Thyroid carcinoma metastasis to skull with infringement of brain: treatment with radioiodine.
Thyroid : official journal of the American Thyroid Association 2009;19(3):297-303.
2008: James C Sisson; Matthew Schipper; Christine C Nelson; John E Freitas; Bartley R Frueh
Radioiodine therapy and Graves' ophthalmopathy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2008;49(6):923-30.
2007: James C Sisson; Anca M Avram; Domenico Rubello; Milton D Gross
Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?
European journal of nuclear medicine and molecular imaging 2007;34(7):1129-30.
2006: James C Sisson; Anca M Avram; Susan A Lawson; Paul G Gauger; Gerard M Doherty
The so-called stunning of thyroid tissue.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(9):1406-12.
2006: James C Sisson; Barry L Shulkin; Nazanene Esfandiari
Courses of malignant pheochromocytoma: implications for therapy.
Annals of the New York Academy of Sciences 2006;1073():505-11.
2006: Barry L Shulkin; Ioannis Ilias; James C Sisson; Karel Pacak
Current trends in functional imaging of pheochromocytomas and paragangliomas.
Annals of the New York Academy of Sciences 2006;1073():374-82.
2006: Adam Tonakie; Barry L Shulkin; James C Sisson; Gregory Yanik; Raymond J Hutchinson
Radiation-induced osteosarcoma and papillary carcinoma of the thyroid.
Clinical nuclear medicine 2006;31(1):5-8.
2004: Anca M Avram; Robert Gielczyk; Lyndon Su; Andrew K Vine; James C Sisson
Choroidal and skin metastases from papillary thyroid cancer: case and a review of the literature.
The Journal of clinical endocrinology and metabolism 2004;89(11):5303-7.
2004: Anca M Avram; Christine A Sturm; Claire W Michael; James C Sisson; Craig A Jaffe
Cryptococcal thyroiditis and hyperthyroidism.
Thyroid : official journal of the American Thyroid Association 2004;14(6):471-4.
2003: Judiann Miskulin; Barry L Shulkin; Gerard M Doherty; James C Sisson; Richard E Burney; Paul G Gauger
Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma?
Surgery 2003;134(6):918-22; discussion 922-3.
2003: David Axelrod; James C Sisson; Kyung J Cho; Judiann Miskulin; Paul G Gauger
Appearance of ectopic undescended inferior parathyroid adenomas on technetium Tc 99m sestamibi scintigraphy: a lesson from reoperative parathyroidectomy.
Archives of surgery (Chicago, Ill. : 1960) 2003;138(11):1214-8.
2003: James C Sisson; Barry L Shulkin; Susan Lawson
Increasing efficacy and safety of treatments of patients with well-differentiated thyroid carcinoma by measuring body retentions of 131I.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(6):898-903.
2002: James C Sisson
Radiopharmaceutical treatment of pheochromocytomas.
Annals of the New York Academy of Sciences 2002;970():54-60.
2002: Gregory Yanik; John E Levine; Katherine K Matthay; James C Sisson; Barry L Shulkin; Brahm Shapiro; David Hubers; Susan Spalding; Thomas Braun; James L M Ferrara; Raymond J Hutchinson
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2142-9.
2002: James C Sisson
Practical dosimetry of 131I in patients with thyroid carcinoma.
Cancer biotherapy & radiopharmaceuticals 2002;17(1):101-5.
2001: James C Sisson; JE Carey
Thyroid carcinoma with high levels of function: treatment with (131)I.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2001;42(6):975-83.
2000: James C Sisson
Radiopharmaceuticals for nuclear endocrinology at the University of Michigan.
Cancer biotherapy & radiopharmaceuticals 2000;15(4):305-18.
2000: James C Sisson; Norman W Thompson; Thomas J Giordano; Barry G England; Daniel Normolle
Serum thyroglobulin levels after thyroxine withdrawal in patients with low risk papillary thyroid carcinoma.
Thyroid : official journal of the American Thyroid Association 2000;10(2):165-9.
1999: James C Sisson; Barry L Shulkin
Nuclear medicine imaging of pheochromocytoma and neuroblastoma.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1999;43(3):217-23.
1999: James C Sisson; Brahm Shapiro; Barry L Shulkin; Susan G Urba; S Zempel; S Spaulding
Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy.
American journal of clinical oncology 1999;22(4):364-70.
1999: Barry L Shulkin; Norman W Thompson; Brahm Shapiro; Isaac R Francis; James C Sisson
Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET.
Radiology 1999;212(1):35-41.
1998: James C Sisson; David A Jamadar; Ella Annabelle Kazerooni; Thomas J Giordano; JE Carey; S A Spaulding
Treatment of micronodular lung metastases of papillary thyroid cancer: are the tumors too small for effective irradiation from radioiodine?
Thyroid : official journal of the American Thyroid Association 1998;8(3):215-21.
1997: A Leung; Brahm Shapiro; R Hattner; E Kim; Jan de Kraker; N Ghazzar; O Hartmann; Cornelis A Hoefnagel; David A Jamadar; Richard T Kloos; P Lizotte; J Lumbroso; Vittoria Rufini; Barry L Shulkin; James C Sisson; A Thein; Luigi Troncone
Specificity of radioiodinated MIBG for neural crest tumors in childhood.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(9):1352-7.
1997: James C Sisson
Selection of the optimal scanning agent for thyroid cancer.
Thyroid : official journal of the American Thyroid Association 1997;7(2):295-302.
1996: James C Sisson; Thomas J Giordano; David A Jamadar; Ella Annabelle Kazerooni; Brahm Shapiro; Milton D Gross; S A Zempel; S A Spaulding
131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma.
Cancer 1996;78(10):2184-92.
1996: Vittoria Rufini; G A Fisher; Barry L Shulkin; James C Sisson; Brahm Shapiro
Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(9):1464-8.
1996: Barry L Shulkin; Raymond J Hutchinson; Valerie P Castle; Gregory Yanik; Brahm Shapiro; James C Sisson
Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.
Radiology 1996;199(3):743-50.
1996: Roma Y Gianchandani; G A Quin; Roger J Grekin; Milton D Gross; James C Sisson; Norman W Thompson; Brahm Shapiro
Simultaneous scintigraphic depiction of aldosteronoma and adrenal infarction.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(5):852-4.
1996: James C Sisson; Brahm Shapiro; Raymond J Hutchinson; Barry L Shulkin; S Zempel
Survival of patients with neuroblastoma treated with 125-I MIBG.
American journal of clinical oncology 1996;19(2):144-8.
1996: Barry L Shulkin; Darryl Wieland; M E Baro; D R Ungar; D S Mitchell; M G Dole; J B Rawwas; Valerie P Castle; James C Sisson; Raymond J Hutchinson
PET hydroxyephedrine imaging of neuroblastoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(1):16-21.
1995: Brahm Shapiro; James C Sisson; Barry L Shulkin; Milton D Gross; S Zempel
The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1995;39(4 Suppl 1):55-7.
1995: Brahm Shapiro; James C Sisson; Barry L Shulkin; Milton D Gross; S Zempel
The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1995;39(4 Suppl 1):3-8.
1995: Fredric Wolf; James C Sisson; AJ Zweifler
A standardized patient program to evaluate summarization skills in patient interviews.
Academic medicine : journal of the Association of American Medical Colleges 1995;70(5):443.
1994: Brahm Shapiro; Barry L Shulkin; Raymond J Hutchinson; J C Bass; Milton D Gross; James C Sisson
Locating neuroblastoma in the opsoclonus-myoclonus syndrome.
Journal of nuclear biology and medicine (Turin, Italy : 1991) 1994;38(4):545-55.
1994: James C Sisson; Brahm Shapiro; Raymond J Hutchinson; JE Carey; Kenneth R Zasadny; S A Zempel; Daniel Normolle
Predictors of toxicity in treating patients with neuroblastoma by radiolabeled metaiodobenzylguanidine.
European journal of nuclear medicine 1994;21(1):46-52.
1993: James C Sisson; R J Ackermann; M A Meyer; Richard L Wahl
Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapy.
The Journal of clinical endocrinology and metabolism 1993;77(4):1090-4.
1992: Barry L Shulkin; Darryl Wieland; M Schwaiger; Norman W Thompson; Isaac R Francis; M S Haka; K C Rosenspire; Brahm Shapiro; James C Sisson; David E Kuhl
PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(6):1125-31.
1992: Raymond J Hutchinson; James C Sisson; Brahm Shapiro; J S Miser; D Normole; Barry L Shulkin; Isaac R Francis; Kenneth R Zasadny; JE Carey; J W Johnson
131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastoma.
American journal of clinical oncology 1992;15(3):226-32.
1991: James C Sisson; M B Donnelly; G E Hess; James O Woolliscroft
The characteristics of early diagnostic hypotheses generated by physicians (experts) and students (novices) at one medical school.
Academic medicine : journal of the Association of American Medical Colleges 1991;66(10):607-12.
1991: Brahm Shapiro; James C Sisson; Darryl Wieland; Thomas J Mangner; S M Zempel; E Mudgett; Milton D Gross; JE Carey; Kenneth R Zasadny; W H Beierwaltes
Radiopharmaceutical therapy of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: results from ten years of experience.
Journal of nuclear biology and medicine (Turin, Italy : 1991) 1991;35(4):269-76.
1991: James C Sisson; Brahm Shapiro; Raymond J Hutchinson; Kenneth R Zasadny; S Mallette; E E Mudgett; Darryl Wieland
Treatment of neuroblastoma with [125I]metaiodobenzylguanidine.
Journal of nuclear biology and medicine (Turin, Italy : 1991) 1991;35(4):255-9.
1991: Raymond J Hutchinson; James C Sisson; J S Miser; Kenneth R Zasadny; Daniel Normolle; Barry L Shulkin; Isaac R Francis; Darryl Wieland; Brahm Shapiro
Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma.
Journal of nuclear biology and medicine (Turin, Italy : 1991) 1991;35(4):237-40.
1991: James C Sisson; B De Bernardi
Session on the biology and treatment of neuroblastoma as related to metaiodobenzylguanidine. Chairmen's report.
Journal of nuclear biology and medicine (Turin, Italy : 1991) 1991;35(4):199-201.
1991: James C Sisson; Darryl Wieland; Robert A Koeppe; Daniel Normolle; Kirk A Frey; Gerald R Bolgos; J Johnson; Marcian E Van Dort; D L Gildersleeve
Scintigraphic portrayal of beta receptors in the heart.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(7):1399-407.
1991: James C Sisson; Gerald R Bolgos; J Johnson
Measuring acute changes in adrenergic nerve activity of the heart in the living animal.
American heart journal 1991;121(4 Pt 1):1119-23.
1991: F A Khafagi; Brahm Shapiro; M Fischer; James C Sisson; Raymond J Hutchinson; W H Beierwaltes
Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine.
European journal of nuclear medicine 1991;18(3):191-8.
1990: James C Sisson; Raymond J Hutchinson; Brahm Shapiro; Kenneth R Zasadny; Daniel Normolle; Darryl Wieland; Richard L Wahl; D A Singer; S A Mallette; E E Mudgett
Iodine-125-MIBG to treat neuroblastoma: preliminary report.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(9):1479-85.
1990: Ella Annabelle Kazerooni; James C Sisson; Brahm Shapiro; Milton D Gross; A Driedger; G A Hurwitz; A G Mattar; Neil Petry
Diagnostic accuracy and pitfalls of [iodine-131]6-beta-iodomethyl-19-norcholesterol (NP-59) imaging.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(4):526-34.
1990: James C Sisson; J Johnson; Gerald R Bolgos; J J Lynch; A Uprichard; Edward M Driscoll; Darryl Wieland; Benedict R Lucchesi
Portrayal of adrenergic denervation in the presence of myocardial infarction: a feasibility study.
American journal of physiologic imaging 1990;5(4):151-66.
1989: James C Sisson; Brahm Shapiro
Metaiodobenzylguanidine for cardiac and tumor imaging.
Current opinion in radiology 1989;1(4):485-91.
1989: M C Tobes; Lorraine M Fig; J Carey; O Geatti; James C Sisson; Brahm Shapiro
Alterations of iodine-131 MIBG biodistribution in an anephric patient: comparison to normal and impaired renal function.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(9):1476-82.
1989: Kenneth F Koral; X H Wang; James C Sisson; J Botti; L Meyer; S Mallette; G M Glazer; R S Adler
Calculating radiation absorbed dose for pheochromocytoma tumors in 131-I MIBG therapy.
International journal of radiation oncology, biology, physics 1989;17(1):211-8.
1989: F A Khafagi; Brahm Shapiro; Lorraine M Fig; S Mallette; James C Sisson
Labetalol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(4):481-9.
1988: J K Kahn; James C Sisson; A I Vinik
Prediction of sudden cardiac death in diabetic autonomic neuropathy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(9):1605-6.
1988: James C Sisson; J J Lynch; J Johnson; S Jaques; D Wu; Gerald R Bolgos; Benedict R Lucchesi; Darryl Wieland
Scintigraphic detection of regional disruption of adrenergic neurons in the heart.
American heart journal 1988;116(1 Pt 1):67-76.
1988: J J Yobbagy; R Levatter; James C Sisson; Barry L Shulkin; Theodore Z Polley
Scintigraphic portrayal of the syndrome of multiple endocrine neoplasia type-2B.
Clinical nuclear medicine 1988;13(6):433-7.
1988: Barry L Shulkin; James C Sisson; Kenneth F Koral; Brahm Shapiro; X H Wang; J Johnson
Conjugate view gamma camera method for estimating tumor uptake of iodine-131 metaiodobenzylguanidine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(4):542-8.
1988: O Geatti; Brahm Shapiro; Barry L Shulkin; Raymond J Hutchinson; James C Sisson
Gastrointestinal iodine-131-meta-iodobenzylguanidine activity.
American journal of physiologic imaging 1988;3(4):188-91.
1988: James C Sisson; Raymond J Hutchinson; JE Carey; Brahm Shapiro; J W Johnson; S A Mallette; Darryl Wieland
Toxicity from treatment of neuroblastoma with 131I-meta-iodobenzylguanidine.
European journal of nuclear medicine 1988;14(7-8):337-40.
1987: Barry L Shulkin; Brahm Shapiro; James C Sisson
Pheochromocytoma, polycythemia, and venous thrombosis.
The American journal of medicine 1987;83(4):773-6.
1987: James C Sisson; Brahm Shapiro; L Meyers; S Mallette; Thomas J Mangner; Darryl Wieland; J V Glowniak; P Sherman; W H Beierwaltes
Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(10):1625-36.
1987: James C Sisson; Darryl Wieland; P Sherman; Thomas J Mangner; M C Tobes; S Jacques
Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(10):1620-4.
1987: S Jaques; M C Tobes; James C Sisson
Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one.
Cancer research 1987;47(15):3920-8.
1987: Milton D Gross; Brahm Shapiro; James C Sisson; AJ Zweifler
Clonidine-induced suppression of plasma catecholamines in states of adrenal medulla hyperfunction.
Journal of endocrinological investigation 1987;10(4):359-64.
1987: Barry L Shulkin; S W Shen; James C Sisson; Brahm Shapiro
Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(3):315-8.
1987: James C Sisson; Darryl Wieland; S Jaques; P Sherman; S Fisher; S Mallette; L Meyers; Thomas J Mangner
Radiolabeled meta-iodobenzylguanidine and the adrenergic neurons of salivary glands.
American journal of physiologic imaging 1987;2(1):1-9.
1986: Barry L Shulkin; Brahm Shapiro; Isaac R Francis; R Dorr; S W Shen; James C Sisson
Primary extra-adrenal pheochromocytoma: positive I-123 MIBG imaging with negative I-131 MIBG imaging.
Clinical nuclear medicine 1986;11(12):851-4.
1986: N B Arnstein; JE Carey; S A Spaulding; James C Sisson
Determination of iodine-131 diagnostic dose for imaging metastatic thyroid cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1986;27(11):1764-9.
1986: Barry L Shulkin; Brahm Shapiro; M C Tobes; S W Shen; Darryl Wieland; L J Meyers; H T Lee; Neil Petry; James C Sisson; W H Beierwaltes
Iodine-123-4-amino-3-iodobenzylguanidine, a new sympathoadrenal imaging agent: comparison with iodine-123 metaiodobenzylguanidine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1986;27(7):1138-42.
1986: Thomas J Mangner; M C Tobes; D W Wieland; James C Sisson; Brahm Shapiro
Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1986;27(1):37-44.
1986: James C Sisson; Darryl Wieland
Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies.
American journal of physiologic imaging 1986;1(2):96-103.
1985: M C Tobes; S Jaques; Darryl Wieland; James C Sisson
Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1985;26(8):897-907.
1985: O Geatti; Brahm Shapiro; James C Sisson; Raymond J Hutchinson; S Mallette; P Eyre; W H Beierwaltes
Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1985;26(7):736-42.
1985: M D Lynn; Brahm Shapiro; James C Sisson; W H Beierwaltes; L J Meyers; R Ackerman; Thomas J Mangner
Pheochromocytoma and the normal adrenal medulla: improved visualization with I-123 MIBG scintigraphy.
Radiology 1985;155(3):789-92.
1985: Brahm Shapiro; J E Copp; James C Sisson; P L Eyre; J Wallis; W H Beierwaltes
Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1985;26(6):576-85.
1985: Brahm Shapiro; James C Sisson; P Eyre; J E Copp; C Dmuchowski; W H Beierwaltes
131I-MIBG--a new agent in diagnosis and treatment of pheochromocytoma.
Cardiology 1985;72 Suppl 1():137-42.
1984: S Jaques; M C Tobes; James C Sisson; J A Baker; Darryl Wieland
Comparison of the sodium dependency of uptake of meta-lodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells.
Molecular pharmacology 1984;26(3):539-46.
1984: M D Lynn; Brahm Shapiro; James C Sisson; D P Swanson; Thomas J Mangner; Darryl Wieland; L J Meyers; J V Glowniak; W H Beierwaltes
Portrayal of pheochromocytoma and normal human adrenal medulla by m-[123I]iodobenzylguanidine: concise communication.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1984;25(4):436-40.
1984: James C Sisson; Brahm Shapiro; W H Beierwaltes; J V Glowniak; M Nakajo; Thomas J Mangner; JE Carey; D P Swanson; J E Copp; W G Satterlee
Radiopharmaceutical treatment of malignant pheochromocytoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1984;25(2):197-206.
1981: James C Sisson; M S Frager; T W Valk; Milton D Gross; D P Swanson; Darryl Wieland; M C Tobes; W H Beierwaltes; Norman W Thompson
Scintigraphic localization of pheochromocytoma.
The New England journal of medicine 1981;305(1):12-7.
1981: T W Valk; M S Frager; Milton D Gross; James C Sisson; Darryl Wieland; D P Swanson; Thomas J Mangner; W H Beierwaltes
Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-metaiodobenzylguanidine.
Annals of internal medicine 1981;94(6):762-7.